Business
Federal government buys 300,000 doses of Merck COVID-19 treatment drug molnupiravir that has not yet been approved – ABC News
Merck’s COVID treatment drug, molnupiravir, has only passed the first hurdle towards approval in Australia but the federal government…
While Australia is still trying to reach its COVID-19 vaccination targets, treatment options for the virus are set to become increasingly important going forward.
The federal government is so keen on one potential treatment option, it has bought 300,000…
Continue Reading
-
Noosa News20 hours agoYoung voices shape Sunshine Coast’s future
-
Business19 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News18 hours agoAnother All-Star Cast, Another Tale of Family Chaos: The Trailer for Wes Anderson’s ‘The Phoenician Scheme’ Is Here
-
Business16 hours agoshould I buy hedged or unhedged ASX US-focused ETFs?